Compare MESO & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MESO | NRDS |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.0B |
| IPO Year | N/A | 2021 |
| Metric | MESO | NRDS |
|---|---|---|
| Price | $19.15 | $14.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $24.00 | $15.40 |
| AVG Volume (30 Days) | 263.7K | ★ 872.7K |
| Earning Date | 08-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.93 |
| Revenue | $17,198,000.00 | ★ $795,000,000.00 |
| Revenue This Year | $465.44 | $22.09 |
| Revenue Next Year | $75.37 | $7.18 |
| P/E Ratio | ★ N/A | $15.28 |
| Revenue Growth | ★ 191.39 | 24.71 |
| 52 Week Low | $9.61 | $7.55 |
| 52 Week High | $22.00 | $16.24 |
| Indicator | MESO | NRDS |
|---|---|---|
| Relative Strength Index (RSI) | 63.12 | 47.82 |
| Support Level | $17.48 | $13.58 |
| Resistance Level | $19.90 | $15.13 |
| Average True Range (ATR) | 0.60 | 0.51 |
| MACD | 0.12 | -0.18 |
| Stochastic Oscillator | 76.13 | 21.83 |
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.